| 1. | | Completed | A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
Condition: HIV Infections |
| 2. | | No longer recruiting | (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
Conditions: Cancer; Central Nervous System Disease; Nervous System Disease; Peripheral Nervous System Disease; Progressive Multifocal Leukoencephalopathy |
| 3. | | Completed | (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC
Condition: HIV Infections |
| 4. | | Suspended | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma |
| 5. | | No longer recruiting | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C |
| 6. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 7. | | Recruiting | A 14-day study of Racivir when used in combination in HIV-Infected Males
Condition: HIV Infections |
| 8. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 9. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 10. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma
Condition: Cancer |
| 11. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery
Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ... |
| 12. | | Completed | A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients with AIDS
Conditions: Cryptosporidiosis; HIV Infections |
| 13. | | Completed | 3TC (Lamivudine; GR109714X) Open-Label Program
Condition: HIV Infections |
| 14. | | Recruiting | 4-Day-A-Week Treatment Plan for HIV Infected Adolescents
Condition: HIV Infections |
| 15. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections |
| 16. | | No longer recruiting | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 17. | | No longer recruiting | 506U78 in Treating Patients With Lymphoma
Conditions: Leukemia; Lymphoma |
| 18. | | No longer recruiting | 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult T-cell leukemia/lymphoma; angioimmunoblastic T-cell lymphoma; ... |
| 19. | | No longer recruiting | 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ... |
| 20. | | Completed | ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
Condition: HIV Infections |
| 21. | | Recruiting | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases |
| 22. | | Completed | Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity
Condition: HIV Infections |
| 23. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy |
| 24. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
| 25. | | Terminated | Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)
Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
| 26. | | Recruiting | Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients
Condition: HIV Infections |
| 27. | | Completed | Acupuncture and Herbal Treatment of Chronic HIV Sinusitis
Conditions: HIV Infections; Sinusitis |
| 28. | | Recruiting | Acupuncture and Moxa: A RCT for Chronic Diarrhea in HIV Patients
Condition: HIV Infections |
| 29. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
| 30. | | No longer recruiting | Adding New Drugs for HIV Infected Patients Failing Current Therapy
Condition: HIV Infections |
| 31. | | Completed | Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
Condition: HIV Infections |
| 32. | | Terminated | The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
Condition: HIV Infections |
| 33. | | No longer recruiting | Addition of ISIS 14803 to Therapy with Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) patients not Responding Adequately to the Two Drugs
Condition: Hepatitis C, Chronic |
| 34. | | Completed | Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients
Conditions: Hepatitis B; HIV Infection |
| 35. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
| 36. | | No longer recruiting | Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs
Condition: HIV Infections |
| 37. | | Completed | Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
| 38. | | Completed | Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy
Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
| 39. | | Completed | AIDS Wasting in Women: Anabolic Effects of Testosterone
Condition: AIDS Wasting Syndrome |
| 40. | | Completed | AIDS-Associated Cardiomyopathy
Conditions: Acquired Immunodeficiency Syndrome; Heart Diseases; Myocardial Diseases; HIV Infections |
| 41. | | Completed | AIDS-Associated Heart Disease -- Incidence and Etiology
Conditions: Heart Diseases; Acquired Immunodeficiency Syndrome; Myocardial Diseases; HIV Infections |
| 42. | | Not yet recruiting | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; Non-Hodgkin's Lymphoma; ... |
| 43. | | Recruiting | Alternative Dosing Strategy for Anti-HIV Drugs
Condition: HIV Infections |
| 44. | | No longer recruiting | Alternative Stress Management Approaches in HIV Disease
Condition: HIV Infections |
| 45. | | Completed | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer
Conditions: epidemic Kaposi's sarcoma; recurrent Kaposi's sarcoma; AIDS-related peripheral/systemic lymphoma |
| 46. | | No longer recruiting | ALVAC-HIV vCP1452 Alone and Combined with MN rgp120
Conditions: HIV Infections; HIV Seronegativity |
| 47. | | No longer recruiting | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Lung Cancer; Ovarian Cancer; Lymphoma; Leukemia; Breast Cancer |
| 48. | | Completed | Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Patients Following Failure with Kaletra (lopinavir/ritonavir) as Their Second Protease Inhibitor.
Condition: HIV Infections |
| 49. | | Completed | Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Patients Following Failure with Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Condition: HIV Infections |
| 50. | | Recruiting | Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy
Condition: HIV Infection |
